Q&A With Gary Franklin, MD, MPH, FAAN, of the University of Washington: The Opioid Epidemic: Where Do We Go From Here?

Video

The opioid epidemic began nearly 30 years ago and since that time small steps have been taken to reverse its effects. The question remains whether too much damage has already been done to fix the problems in a timely manner.

The opioid epidemic began nearly 30 years ago and since that time small steps have been taken to reverse its effects. The question remains whether too much damage has already been done to fix the problems in a timely manner.

Gary Franklin, MD, MPH, FAAN, from the University of Washington discussed what needs to be done to ensure patients get the care they need without becoming addicted to opioid medications during the American Academy of Neurology's annual meeting in Washington DC. Franklin noted that even the opioid meciations that have been developed to protect against abuse have not made a significant impact in stopping the spread of the epidemic.

Related Videos
Katharine Phillips, MD: Differences Between OCD, Body Dysmorphic Disorder
Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates
Brian Barnett, MD: Psychedelics Fitting into the SUDs Treatment Paradigm
Lenard A. Adler, MD: “Symptoms of ADHD Need to Go Back to Childhood”
Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn
3 Barriers to Improving Clozapine Use in Treatment-Resistant Schizophrenia
Evaluating MM120 for GAD with Daniel Karlin, MD, and Reid Robinson, MD, MBA
Daniel Karlin, MD: Prevalence of Undiagnosed Generalized Anxiety Disorder
© 2024 MJH Life Sciences

All rights reserved.